CYSE News Search

Dr. Edward V. Nunes will serve as one of the directors of Columbia's Center for Healing of Opioid and Other Substance Use Disorders-Enhancing Intervention, Development and Implementation (CHOSEN).

“Anxiety, when it’s at the right level, encourages us to take positive action,” said Dr. Kelli Harding.

The results "indicate that KarXT, if approved, could represent a game-changing therapeutic advance in the treatment of patients with schizophrenia,” noted Dr. Jeffrey Lieberman.

The study "contributes to efforts that may one day redefine the diagnostic system in psychiatry, which may have practical clinical implications," commented Dr. Tiffany Herlands.